India rebuffs Lilly patent claim on Cialis
Regulators in India have rejected a patent claim by Indianapolis-based Eli Lilly and Co. for its Cialis erectile dysfunction drug. The drug’s basic components were synthesized in 1970 by Indian scientists at a government body that researches pharmaceuticals, the Central Drug Research Institute, an Indian drugmaker contended. Moreover, drugmaker Ajanta Pharma argued, the Indian scientists […]